199 related articles for article (PubMed ID: 6163417)
1. Interferon therapy: pharmacokinetic and pharmacological aspects.
Billiau A
Arch Virol; 1981; 67(2):121-33. PubMed ID: 6163417
[No Abstract] [Full Text] [Related]
2. Pharmacokinetic and pharmacological aspects of interferon therapy in man.
Billiau A
Acta Microbiol Acad Sci Hung; 1981; 28(3):257-62. PubMed ID: 6171139
[No Abstract] [Full Text] [Related]
3. Recent advances in the study of interferon.
Ho M
Pharmacol Rev; 1982 Mar; 34(1):119-29. PubMed ID: 6175986
[No Abstract] [Full Text] [Related]
4. Interferons: anti-neoplastic drugs?
Strander H
Blut; 1977 Sep; 35(4):277-88. PubMed ID: 334285
[No Abstract] [Full Text] [Related]
5. Implications for clinical application of new developments in interferon research.
Taylor-Papadimitriou J; Balkwill FR
Biochim Biophys Acta; 1982 Sep; 695(1):49-67. PubMed ID: 6182911
[No Abstract] [Full Text] [Related]
6. The use of interferon in viral hepatitis B.
Desmyter J
Tex Rep Biol Med; 1977; 35():516-22. PubMed ID: 358473
[No Abstract] [Full Text] [Related]
7. Interferon therapy.
Alexander MC
NITA; 1987; 10(1):40-2. PubMed ID: 2434885
[No Abstract] [Full Text] [Related]
8. Possible causes of fever after interferon administration.
Bocci VU
Biomedicine; 1980 Dec; 32(4):159-62. PubMed ID: 6162489
[TBL] [Abstract][Full Text] [Related]
9. The clinical value of interferons as antitumor agents.
Billiau A
Eur J Cancer Clin Oncol; 1981 Sep; 17(9):949-67. PubMed ID: 6173223
[No Abstract] [Full Text] [Related]
10. Therapy with interferons in blood diseases.
Polli E; Cortelezzi A
Acta Haematol; 1987; 78 Suppl 1():64-9. PubMed ID: 2449025
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effects of interferon and its possible use as an anti-neoplastic agent in man.
Strander H
Tex Rep Biol Med; 1977; 35():429-35. PubMed ID: 358466
[TBL] [Abstract][Full Text] [Related]
12. Usages of interferon and interferon inducers in man.
Pollard RB
Med Biol; 1980 Apr; 58(2):57-62. PubMed ID: 6159505
[No Abstract] [Full Text] [Related]
13. Measurement of antitumor and adjuvant effects of interferon with transplantable and other tumors in mice.
Chirigos MA
Methods Enzymol; 1981; 79(Pt B):414-9. PubMed ID: 6173688
[No Abstract] [Full Text] [Related]
14. [Problems in the clinical evaluation of interferon].
Zanussi C
Ann Ist Super Sanita; 1987; 23(4):779-85. PubMed ID: 2454600
[No Abstract] [Full Text] [Related]
15. Why do so many cancer patients fail to respond to interferon therapy?
Einhorn S; Grander D
J Interferon Cytokine Res; 1996 Apr; 16(4):275-81. PubMed ID: 9162520
[TBL] [Abstract][Full Text] [Related]
16. Present status and future problems of interferon in the treatment of hematological malignancies.
Kimura K
Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1677-87. PubMed ID: 2425532
[No Abstract] [Full Text] [Related]
17. Interferon, preclinical basis for clinical trials with fibroblast interferon in Japan.
Kataoka T; Sakurai Y; Ida N; Kobayashi S
Cancer Treat Rev; 1980 Dec; 7(4):253-6. PubMed ID: 6163536
[No Abstract] [Full Text] [Related]
18. Interferon-induced skin reactivity in man.
De Somer P; Edy VG; Billiau A
Lancet; 1977 Jul; 2(8027):47-8. PubMed ID: 69141
[No Abstract] [Full Text] [Related]
19. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
[TBL] [Abstract][Full Text] [Related]
20. Interferons in cancer therapy: a reappraisal.
Balkwill FR; Smyth JF
Lancet; 1987 Aug; 2(8554):317-9. PubMed ID: 2441217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
